This inventor holds 1 USPTO granted patent. Top assignees: Council of Scientific and Industrial Research, Indian Veterinary Research Institute, Unichem Laboratories Limited. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2,130 
1 out of 1 
1 out of 24 Years Active: 2011
Title: Inventor Mohammad Shahnawaz: Pioneering a Chimeric Rabies Vaccine
Introduction
Mohammad Shahnawaz, an innovative inventor based in Uttar Pradesh, India, has made significant contributions to the field of biotechnology. With a focus on developing novel solutions for viral infections, he has successfully secured a patent for a groundbreaking rabies vaccine.
Latest Patents
Shahnawaz's patent, titled "Chimeric G protein based rabies vaccine," showcases his ingenuity in designing a novel chimeric protein derived from the rabies virus. This innovative vaccine utilizes transgenic plants, specifically tobacco, to express a high level of a chimeric G protein. The gene encoding this protein was chemically synthesized and expressed in plant tissue. The efficacy of this plant-derived chimeric G protein was rigorously tested, and the results indicated a significantly higher immune response compared to commercial vaccines. Notably, the immunized BalbC mice exhibited protective immunity when challenged with the live rabies virus, positioning this chimeric G protein as a commercially viable subunit vaccine against rabies.
Career Highlights
Throughout his career, Mohammad Shahnawaz has been associated with esteemed organizations such as the Council of Scientific and Industrial Research and Unichem Laboratories Limited. His work in these institutions has fortified his expertise in the field, allowing him to effectively contribute to advancements in vaccine development.
Collaborations
Shahnawaz has collaborated with various talented individuals, including colleagues Rakesh Tuli and Samir Vishwanath Sawant. Their combined efforts have furthered the research and development of innovative biotechnological solutions.
Conclusion
Mohammad Shahnawaz's dedication to innovation is evident in his pioneering work on a chimeric G protein-based rabies vaccine. His contributions not only enhance the field of vaccine development but also demonstrate the potential of plant biotechnology in addressing critical health challenges. As he continues to advance in his career, Shahnawaz remains a notable figure in the realm of scientific innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile